{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:47Z","timestamp":1786982207381,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["DST\/INSPIRE Fellowship\/09\/IF90083"],"award-info":[{"award-number":["DST\/INSPIRE Fellowship\/09\/IF90083"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["DBT-NNP No.BT\/PR40156\/BTIS\/137\/54\/2023"],"award-info":[{"award-number":["DBT-NNP No.BT\/PR40156\/BTIS\/137\/54\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Promotion of University Research and Scientific ExcellenceIndia","award":["No. SR\/PURSE Phase 2\/38(G), 2017"],"award-info":[{"award-number":["No. SR\/PURSE Phase 2\/38(G), 2017"]}]},{"name":"MDRD-RUSA","award":["F.24e51\/2014-U"],"award-info":[{"award-number":["F.24e51\/2014-U"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03163-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T09:58:39Z","timestamp":1766743119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rational design and structural Bioinformatics-Driven discovery of tetrapeptide inhibitors for LIMK-Targeted cancer therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Nagarajan","family":"Hemavathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampathkumar","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetrivel","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyaraman","family":"Jeyakanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"3163_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1349-7006.2005.00062.x","volume":"96","author":"D Yamazaki","year":"2005","unstructured":"Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005;96:379\u201386. https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00062.x.","journal-title":"Cancer Sci"},{"key":"3163_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2007;1773:642\u201352. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.07.001.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"3163_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ydbio.2003.06.003","volume":"265","author":"M Raftopoulou","year":"2004","unstructured":"Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol. 2004;265:23\u201332. https:\/\/doi.org\/10.1016\/j.ydbio.2003.06.003.","journal-title":"Dev Biol"},{"key":"3163_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010142","author":"D Chatterjee","year":"2022","unstructured":"Chatterjee D, Preuss F, Dederer V, Knapp S, Mathea S. Structural aspects of LIMK regulation and pharmacology. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11010142.","journal-title":"Cells"},{"key":"3163_CR5","doi-asserted-by":"publisher","first-page":"13692","DOI":"10.1074\/jbc.M610873200","volume":"282","author":"M Endo","year":"2007","unstructured":"Endo M, Ohashi K, Mizuno K. Lim kinase and slingshot are critical for neurite extension. J Biol Chem. 2007;282:13692\u2013702. https:\/\/doi.org\/10.1074\/jbc.M610873200.","journal-title":"J Biol Chem"},{"key":"3163_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216207","volume":"565","author":"K Shah","year":"2023","unstructured":"Shah K, Cook M. LIMK2: a multifaceted kinase with pleiotropic roles in human physiology and pathologies. Cancer Lett. 2023;565:216207. https:\/\/doi.org\/10.1016\/j.canlet.2023.216207.","journal-title":"Cancer Lett"},{"key":"3163_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/12963","volume":"1","author":"DC Edwards","year":"1999","unstructured":"Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac\/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol. 1999;1:253\u20139. https:\/\/doi.org\/10.1038\/12963.","journal-title":"Nat Cell Biol"},{"key":"3163_CR8","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1074\/jbc.275.5.3577","volume":"275","author":"K Ohashi","year":"2000","unstructured":"Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem. 2000;275:3577\u201382. https:\/\/doi.org\/10.1074\/jbc.275.5.3577.","journal-title":"J Biol Chem"},{"key":"3163_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202400184","volume":"47","author":"G Casanova-Sep\u00falveda","year":"2025","unstructured":"Casanova-Sep\u00falveda G, Boggon TJ. Regulation and signaling of the LIM domain kinases. Bioessays. 2025;47:e2400184. https:\/\/doi.org\/10.1002\/bies.202400184.","journal-title":"Bioessays"},{"key":"3163_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/31729","volume":"393","author":"S Arber","year":"1998","unstructured":"Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature. 1998;393:805\u20139. https:\/\/doi.org\/10.1038\/31729.","journal-title":"Nature"},{"key":"3163_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102726","volume":"10","author":"J Bamburg","year":"2021","unstructured":"Bamburg J, Minamide L, Wiggan O, Tahtamouni L, Kuhn T. Cofilin and actin dynamics: multiple modes of regulation and their impacts in neuronal development and degeneration. Cells. 2021;10:2726. https:\/\/doi.org\/10.3390\/cells10102726.","journal-title":"Cells"},{"key":"3163_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0962-8924(02)02404-2","volume":"12","author":"JR Bamburg","year":"2002","unstructured":"Bamburg JR, Wiggan OP. ADF\/cofilin and actin dynamics in disease. Trends Cell Biol. 2002;12:598\u2013605. https:\/\/doi.org\/10.1016\/S0962-8924(02)02404-2.","journal-title":"Trends Cell Biol"},{"key":"3163_CR13","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1242\/jcs.114.21.3795","volume":"114","author":"T Wittmann","year":"2001","unstructured":"Wittmann T, Waterman-Storer CM. Cell motility: can Rho GTPases and microtubules point the way? J Cell Sci. 2001;114:3795\u2013803. https:\/\/doi.org\/10.1242\/jcs.114.21.3795.","journal-title":"J Cell Sci"},{"key":"3163_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563\u201372. https:\/\/doi.org\/10.1038\/nrc865.","journal-title":"Nat Rev Cancer"},{"key":"3163_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/bj3540149","volume":"354","author":"T Amano","year":"2001","unstructured":"Amano T, Tanabe K, Eto T, Narumiya S, Mizuno K. LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. Biochem J. 2001;354:149\u201359. https:\/\/doi.org\/10.1042\/bj3540149.","journal-title":"Biochem J"},{"key":"3163_CR16","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1073\/pnas.1232344100","volume":"100","author":"K Yoshioka","year":"2003","unstructured":"Yoshioka K, Foletta V, Bernard O, Itoh K. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci U S A. 2003;100:7247\u201352. https:\/\/doi.org\/10.1073\/pnas.1232344100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3163_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.285.5429.895","volume":"285","author":"M Maekawa","year":"1999","unstructured":"Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285:895\u20138. https:\/\/doi.org\/10.1126\/science.285.5429.895.","journal-title":"Science"},{"key":"3163_CR18","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.apsb.2021.01.005","volume":"11","author":"Q Yu","year":"2021","unstructured":"Yu Q, Wu C, Chen Y, Li B, Wang R, Huang R, et al. Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle. Acta Pharm Sin B. 2021;11:1914\u201330. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.005.","journal-title":"Acta Pharm Sin B"},{"key":"3163_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177459","volume":"997","author":"M Lei","year":"2025","unstructured":"Lei M, Lan H, Gu D, Chen M, Qiu X, Cen P, et al. Inhibition of LIMK reduces contraction and proliferation in bladder smooth muscle induced by TGF- \u03b21. Eur J Pharmacol. 2025;997:177459. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177459.","journal-title":"Eur J Pharmacol"},{"key":"3163_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1021\/acs.jmedchem.4c02694","volume":"68","author":"AG Baldwin","year":"2025","unstructured":"Baldwin AG, Foley DW, Collins R, Lee H, Jones DH, Wahab B, et al. Discovery of MDI-114215: a potent and selective LIMK inhibitor to treat fragile X syndrome. J Med Chem. 2025;68:719\u201352. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02694.","journal-title":"J Med Chem"},{"key":"3163_CR21","doi-asserted-by":"publisher","first-page":"153994","DOI":"10.1016\/j.tox.2024.153994","volume":"509","author":"Y Guo","year":"2024","unstructured":"Guo Y, Wang Y, Li Q, Liu Q, Zhang X, Ren J, et al. Bisphenol A disrupts the neuronal F-actin cytoskeleton by activating the RhoA\/ROCK\/LIMK pathway in Neuro-2a cells. Toxicology. 2024;509:153994. https:\/\/doi.org\/10.1016\/j.tox.2024.153994.","journal-title":"Toxicology"},{"key":"3163_CR22","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/cells11132090","volume":"11","author":"R Berabez","year":"2022","unstructured":"Berabez R, Routier S, B\u00e9n\u00e9detti H, Pl\u00e9 K, Vall\u00e9e B. LIM kinases, promising but reluctant therapeutic targets: chemistry and preclinical validation in vivo. Cells. 2022;11:2090. https:\/\/doi.org\/10.3390\/cells11132090.","journal-title":"Cells"},{"key":"3163_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejmech.2018.06.016","volume":"155","author":"F Manetti","year":"2018","unstructured":"Manetti F. Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials. Eur J Med Chem. 2018;155:445\u201358. https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.016.","journal-title":"Eur J Med Chem"},{"key":"3163_CR24","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.2174\/0929867328666211026120335","volume":"29","author":"SNA Bukhari","year":"2022","unstructured":"Bukhari SNA, Tandiary MA, Al-Sanea MM, Abdelgawad MA, Chee CF, Hussain MA. Small molecules as LIM kinase inhibitors. Curr Med Chem. 2022;29:2995\u20133027. https:\/\/doi.org\/10.2174\/0929867328666211026120335.","journal-title":"Curr Med Chem"},{"key":"3163_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107347","volume":"208","author":"C Gong","year":"2024","unstructured":"Gong C, Chang L, Huang R, Sun X, Liu Y, Wu S, et al. LIM kinase 2 activates cardiac fibroblasts and exacerbates postinfarction left ventricular remodeling via crosstalk between the canonical and non-canonical Wnt pathways. Pharmacol Res. 2024;208:107347. https:\/\/doi.org\/10.1016\/j.phrs.2024.107347.","journal-title":"Pharmacol Res"},{"key":"3163_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.781213","author":"D Ariawan","year":"2021","unstructured":"Ariawan D, Au C, Paric E, Fath T, Ke YD, Kassiou M, et al. The nature of diamino linker and halogen bonding define selectivity of pyrrolopyrimidine-based LIMK1 inhibitors. Front Chem. 2021. https:\/\/doi.org\/10.3389\/fchem.2021.781213.","journal-title":"Front Chem"},{"key":"3163_CR27","doi-asserted-by":"publisher","first-page":"38469","DOI":"10.18632\/oncotarget.6288","volume":"6","author":"K Mardilovich","year":"2015","unstructured":"Mardilovich K, Baugh M, Crighton D, Kowalczyk D, Gabrielsen M, Munro J, et al. LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation. Oncotarget. 2015;6:38469\u201386. https:\/\/doi.org\/10.18632\/oncotarget.6288.","journal-title":"Oncotarget"},{"key":"3163_CR28","doi-asserted-by":"publisher","first-page":"13705","DOI":"10.1021\/acs.jmedchem.2c00751","volume":"65","author":"R Collins","year":"2022","unstructured":"Collins R, Lee H, Jones DH, Elkins JM, Gillespie JA, Thomas C, et al. Comparative analysis of small-molecule LIMK1\/2 inhibitors: chemical synthesis, biochemistry, and cellular activity. J Med Chem. 2022;65:13705\u201313. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00751.","journal-title":"J Med Chem"},{"key":"3163_CR29","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1016\/j.bmcl.2011.07.050","volume":"21","author":"BE Sleebs","year":"2011","unstructured":"Sleebs BE, Nikolakopoulos G, Street IP, Falk H, Baell JB. Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors. Bioorg Med Chem Lett. 2011;21:5992\u20134. https:\/\/doi.org\/10.1016\/j.bmcl.2011.07.050.","journal-title":"Bioorg Med Chem Lett"},{"key":"3163_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1091\/mbc.E13-09-0540","volume":"25","author":"K Ohashia","year":"2014","unstructured":"Ohashia K, Sampeia K, Nakagawaa M, Uchiumia N, Amanumaa T, Aibab S, et al. Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion. Mol Biol Cell. 2014;25:828\u201340. https:\/\/doi.org\/10.1091\/mbc.E13-09-0540.","journal-title":"Mol Biol Cell"},{"key":"3163_CR31","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1042\/BCJ20190517","volume":"476","author":"E Salah","year":"2019","unstructured":"Salah E, Chatterjee D, Beltrami A, Tumber A, Preuss F, Canning P, et al. Lessons from LIMK1 enzymology and their impact on inhibitor design. Biochem J. 2019;476:3197\u2013209. https:\/\/doi.org\/10.1042\/BCJ20190517.","journal-title":"Biochem J"},{"key":"3163_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116391","volume":"271","author":"A Champir\u00e9","year":"2024","unstructured":"Champir\u00e9 A, Berabez R, Braka A, Cosson A, Corret J, Girardin C, et al. Tetrahydropyridine LIMK inhibitors: structure activity studies and biological characterization. Eur J Med Chem. 2024;271:116391. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116391.","journal-title":"Eur J Med Chem"},{"key":"3163_CR33","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1021\/acs.jmedchem.2c01106","volume":"65","author":"T Hanke","year":"2022","unstructured":"Hanke T, Mathea S, Woortman J, Salah E, Berger B-T, Tumber A, et al. Development and characterization of type I, type II, and type III LIM-kinase chemical probes. J Med Chem. 2022;65:13264\u201387. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01106.","journal-title":"J Med Chem"},{"key":"3163_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.advms.2023.04.002","volume":"68","author":"N Li","year":"2023","unstructured":"Li N, Cheng Y, Wang S, Liao H, Liu S. Inhibition of airway smooth muscle contraction and proliferation by LIM kinase inhibitor, LIMKi3. Adv Med Sci. 2023;68:186\u201394. https:\/\/doi.org\/10.1016\/j.advms.2023.04.002.","journal-title":"Adv Med Sci"},{"key":"3163_CR35","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/0008-5472.CAN-11-3342","volume":"72","author":"R Prudent","year":"2012","unstructured":"Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, et al. Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Res. 2012;72:4429\u201339. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3342.","journal-title":"Cancer Res"},{"key":"3163_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1506356","author":"OM Lateef","year":"2024","unstructured":"Lateef OM, Foote C, Power G, Manrique-Acevedo C, Padilla J, Martinez-Lemus LA. LIM kinases in cardiovascular health and disease. Front Physiol. 2024. https:\/\/doi.org\/10.3389\/fphys.2024.1506356.","journal-title":"Front Physiol"},{"key":"3163_CR37","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1016\/j.bmcl.2012.07.002","volume":"22","author":"L He","year":"2012","unstructured":"He L, Seitz SP, Trainor GL, Tortolani D, Vaccaro W, Poss M, et al. Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. Bioorg Med Chem Lett. 2012;22:5995\u20138. https:\/\/doi.org\/10.1016\/j.bmcl.2012.07.002.","journal-title":"Bioorg Med Chem Lett"},{"key":"3163_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/31735","volume":"393","author":"N Yang","year":"1998","unstructured":"Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature. 1998;393:809\u201312. https:\/\/doi.org\/10.1038\/31735.","journal-title":"Nature"},{"key":"3163_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/cells12050805","volume":"12","author":"E Villalonga","year":"2023","unstructured":"Villalonga E, Mosrin C, Normand T, Girardin C, Serrano A, \u017dunar B, et al. LIM kinases, LIMK1 and LIMK2, are crucial node actors of the cell fate: molecular to pathological features. Cells. 2023;12:805. https:\/\/doi.org\/10.3390\/cells12050805.","journal-title":"Cells"},{"key":"3163_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1021\/acs.chemrestox.9b00387","volume":"33","author":"SD Lamore","year":"2020","unstructured":"Lamore SD, Kohnken RA, Peters MF, Kolaja KL. Cardiovascular toxicity induced by kinase inhibitors: mechanisms and preclinical approaches. Chem Res Toxicol. 2020;33:125\u201336. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00387.","journal-title":"Chem Res Toxicol"},{"key":"3163_CR41","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1210\/jc.2012-4085","volume":"98","author":"MB Lodish","year":"2013","unstructured":"Lodish MB. Kinase inhibitors: adverse effects related to the endocrine system. J Clin Endocrinol Metab. 2013;98:1333\u201342. https:\/\/doi.org\/10.1210\/jc.2012-4085.","journal-title":"J Clin Endocrinol Metab"},{"key":"3163_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116540","volume":"275","author":"NR Brauer","year":"2024","unstructured":"Brauer NR, Kempen AL, Hernandez D, Sintim HO. Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors. Eur J Med Chem. 2024;275:116540. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116540.","journal-title":"Eur J Med Chem"},{"key":"3163_CR43","doi-asserted-by":"publisher","first-page":"17427","DOI":"10.1021\/acs.jmedchem.5c00974","volume":"68","author":"AG Baldwin","year":"2025","unstructured":"Baldwin AG, Foley DW, Jones DH, Lee H, Collins R, Wahab B, et al. Tetrahydropyrazolopyridinones as a novel class of potent and highly selective LIMK inhibitors. J Med Chem. 2025;68:17427\u201356. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00974.","journal-title":"J Med Chem"},{"key":"3163_CR44","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1158\/1535-7163.MCT-08-0826","volume":"7","author":"P Ross-Macdonald","year":"2008","unstructured":"Ross-Macdonald P, De Silva H, Guo Q, Xiao H, Hung CY, Penhallow B, et al. Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther. 2008;7:3490\u20138. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0826.","journal-title":"Mol Cancer Ther"},{"key":"3163_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02553-7","volume":"22","author":"R Naeimi","year":"2022","unstructured":"Naeimi R, Bahmani A, Afshar S. Investigating the role of peptides in effective therapies against cancer. Cancer Cell Int. 2022;22:139. https:\/\/doi.org\/10.1186\/s12935-022-02553-7.","journal-title":"Cancer Cell Int"},{"key":"3163_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48. https:\/\/doi.org\/10.1038\/s41392-022-00904-4.","journal-title":"Signal Transduct Target Ther"},{"key":"3163_CR47","doi-asserted-by":"publisher","unstructured":"Ciulla MG, Civera M, Sattin S, Kumar K. Nature-inspired and medicinally relevant short peptides. Explor Drug Sci [Internet]. 2023;140\u201371. https:\/\/doi.org\/10.37349\/eds.2023.00011.","DOI":"10.37349\/eds.2023.00011"},{"key":"3163_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0328-x","volume":"24","author":"S Marqus","year":"2017","unstructured":"Marqus S, Pirogova E, Piva TJ. Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci. 2017;24:21. https:\/\/doi.org\/10.1186\/s12929-017-0328-x.","journal-title":"J Biomed Sci"},{"key":"3163_CR49","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.2174\/092986712801661004","volume":"19","author":"RJ Boohaker","year":"2012","unstructured":"Boohaker RJ, Lee MW, Vishnubhotla P, Perez JLM, Khaled AR. The use of therapeutic peptides to target and to kill cancer cells. Curr Med Chem. 2012;19:3794\u2013804. https:\/\/doi.org\/10.2174\/092986712801661004.","journal-title":"Curr Med Chem"},{"key":"3163_CR50","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","volume":"55","author":"SMP Vadevoo","year":"2023","unstructured":"Vadevoo SMP, Gurung S, Lee H-S, Gunassekaran GR, Lee S-M, Yoon J-W, et al. Peptides as multifunctional players in cancer therapy. Exp Mol Med. 2023;55:1099\u2013109. https:\/\/doi.org\/10.1038\/s12276-023-01016-x.","journal-title":"Exp Mol Med"},{"key":"3163_CR51","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1021\/acs.jmedchem.2c01106","volume":"65","author":"T Hanke","year":"2022","unstructured":"Hanke T, Mathea S, Woortman J, Salah E, Berger B-T, Tumber A, et al. Development and characterization of type I, type II, and type III LIM-kinase chemical probes. J Med Chem. 2022;65:13264\u201387. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01106.","journal-title":"J Med Chem"},{"key":"3163_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108289","volume":"115","author":"N Hemavathy","year":"2025","unstructured":"Hemavathy N, Umashankar V, Jeyakanthan J. Unveiling novel type 1 inhibitors for targeting LIM kinase 2 (LIMK2) for cancer therapeutics: an integrative pharmacoinformatics approach. Comput Biol Chem. 2025;115:108289. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108289.","journal-title":"Comput Biol Chem"},{"key":"3163_CR53","doi-asserted-by":"publisher","unstructured":"Lemkul J. From proteins to perturbed hamiltonians: A suite of tutorials for the GROMACS-2018 molecular simulation package [Article v1.0]. Living J Comput Mol Sci [Internet]. 2019;1. https:\/\/doi.org\/10.33011\/livecoms.1.1.5068","DOI":"10.33011\/livecoms.1.1.5068"},{"key":"3163_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017;14:71\u20133. https:\/\/doi.org\/10.1038\/nmeth.4067.","journal-title":"Nat Methods"},{"key":"3163_CR55","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A. 2001;105:9954\u201360. https:\/\/doi.org\/10.1021\/jp003020w.","journal-title":"J Phys Chem A"},{"key":"3163_CR56","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/cbdd.13607","volume":"94","author":"S Ansar","year":"2019","unstructured":"Ansar S, Vetrivel U. PepVis: an integrated peptide virtual screening pipeline for ensemble and flexible docking protocols. Chem Biol Drug Des. 2019;94:2041\u201350. https:\/\/doi.org\/10.1111\/cbdd.13607.","journal-title":"Chem Biol Drug Des"},{"key":"3163_CR57","doi-asserted-by":"publisher","first-page":"15026","DOI":"10.1021\/acs.jmedchem.5c01204","volume":"68","author":"S Mandel","year":"2025","unstructured":"Mandel S, Hanke T, Prendiville N, Baena-Nuevo M, Berger LM, Farges F, et al. Covalent targeting leads to the development of a LIMK1 isoform-selective inhibitor. J Med Chem. 2025;68:15026\u201349. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01204.","journal-title":"J Med Chem"},{"key":"3163_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4442","volume":"31","author":"CHM Rodrigues","year":"2022","unstructured":"Rodrigues CHM, Garg A, Keizer D, Pires DEV, Ascher DB. CSM-peptides: a computational approach to rapid identification of therapeutic peptides. Protein Sci. 2022;31:e4442. https:\/\/doi.org\/10.1002\/pro.4442.","journal-title":"Protein Sci"},{"key":"3163_CR59","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/bioinformatics\/btac006","volume":"38","author":"L Wei","year":"2022","unstructured":"Wei L, Ye X, Sakurai T, Mu Z, Wei L. ToxIBTL: prediction of peptide toxicity based on information bottleneck and transfer learning. Bioinformatics. 2022;38:1514\u201324. https:\/\/doi.org\/10.1093\/bioinformatics\/btac006.","journal-title":"Bioinformatics"},{"key":"3163_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108926","volume":"179","author":"AS Rathore","year":"2024","unstructured":"Rathore AS, Choudhury S, Arora A, Tijare P, Raghava GPS. ToxinPred 3.0: an improved method for predicting the toxicity of peptides. Comput Biol Med. 2024;179:108926. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108926.","journal-title":"Comput Biol Med"},{"key":"3163_CR61","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 2015;43:W443-7. https:\/\/doi.org\/10.1093\/nar\/gkv315.","journal-title":"Nucleic Acids Res"},{"key":"3163_CR62","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, et al. PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res [Internet]. 2021;49:W530\u20134. https:\/\/doi.org\/10.1093\/nar\/gkab294.","journal-title":"Nucleic Acids Res [Internet]"},{"key":"3163_CR63","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng G, Wang E, Wang Z, Liu H, Zhu F, Li D, et al. HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational Docking and MM\/GBSA. Nucleic Acids Res [Internet]. 2019;47:W322\u201330. https:\/\/doi.org\/10.1093\/nar\/gkz397.","journal-title":"Nucleic Acids Res [Internet]"},{"key":"3163_CR64","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E. Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17:6281\u201391. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645.","journal-title":"J Chem Theory Comput"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03163-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03163-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:47:20Z","timestamp":1770389240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03163-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03163-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"83"}}